Exploring Acceptability Drivers of Oral Antibiotics in Children: Findings from an International Observational Study
Overview
Authors
Affiliations
Antibiotics are among the most commonly prescribed drugs in children. Adherence to the treatment with these drugs is of the utmost importance to prevent the emergence of resistant bacteria, a global health threat. In children, medicine acceptability is likely to have a significant impact on compliance. Herein we used a multivariate approach, considering simultaneously the many aspects of acceptability to explore the drivers of oral antibiotic acceptability in children under twelve, especially in toddlers and in preschoolers. Based on 628 real-life observer reports of the intake of 133 distinct medicines, the acceptability reference framework highlighted the influence of many factors such as age and sex of patients, previous exposure to treatment, place of administration, administration device, flavor agent in excipients and active pharmaceutical ingredient. These findings from an international observational study emphasize the multidimensional nature of acceptability. Therefore, it is crucial to consider all these different aspects for assessing this multi-faceted concept and designing or prescribing a medicine in order to reach adequate acceptability in the target population.
Development of a Hydrocortisone Orodispersible Thin Film Containing Its Succinate Prodrug.
Boisseillier C, Demange-Labriet L, Kariyawasam D, Marchadour P, Fauqueur A, Annereau M Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861149 PMC: 11768698. DOI: 10.3390/ph18010086.
Dosage Forms Suitability in Pediatrics: Acceptability of Antibiotics in a German Hospital.
Klingmann V, Vallet T, Munch J, Wolters L, Stegemann R, Bosse H Antibiotics (Basel). 2023; 12(12).
PMID: 38136743 PMC: 10740640. DOI: 10.3390/antibiotics12121709.
A Guide to Best Practice in Sensory Analysis of Pharmaceutical Formulations.
Clapham D, Belissa E, Inghelbrecht S, Pense-Lheritier A, Ruiz F, Sheehan L Pharmaceutics. 2023; 15(9).
PMID: 37765288 PMC: 10535428. DOI: 10.3390/pharmaceutics15092319.
Barbieri E, Minotti C, Cavagnis S, Giaquinto C, Cappello B, Penazzato M Front Pharmacol. 2023; 14:1200848.
PMID: 37529704 PMC: 10390094. DOI: 10.3389/fphar.2023.1200848.
Querin B, Schweitzer-Chaput A, Cisternino S, Auvity S, Fauqueur A, Negbane A Pharmaceutics. 2023; 15(3).
PMID: 36986818 PMC: 10056843. DOI: 10.3390/pharmaceutics15030957.